Statement of Changes in Beneficial Ownership (4)
2013年5月11日 - 5:10AM
Edgar (US Regulatory)
|
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
|
1. Name and Address of Reporting Person
*
MURRAY ROBERT J
|
2. Issuer Name
and
Ticker or Trading Symbol
IDEXX LABORATORIES INC /DE
[
IDXX
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__
X
__ Director
_____ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
|
(Last)
(First)
(Middle)
ONE IDEXX DRIVE
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
5/8/2013
|
|
(Street)
WESTBROOK, ME 04092
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
|
Common Stock
|
5/9/2013
|
|
M
|
|
369
|
A
|
$0
|
16891
(1)
|
D
|
|
|
Common Stock
|
|
|
|
|
|
|
|
15720
|
I
|
by 2010 GRAT
|
|
Common Stock
|
|
|
|
|
|
|
|
10526
|
I
|
by 2012 GRAT
|
|
Common Stock
|
|
|
|
|
|
|
|
2500
|
I
|
by Spouse
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
|
Restricted Stock Unit
|
(2)
|
5/8/2013
|
|
A
|
|
429
|
|
(2)
|
(2)
|
Common Stock
|
429
|
$0
|
798
|
D
|
|
|
Non-Qualified Stock Option (right to buy)
|
$87.36
|
5/8/2013
|
|
A
|
|
4395
|
|
(3)
|
5/7/2023
|
Common Stock
|
4395
|
$0
|
4395
|
D
|
|
|
Restricted Stock Unit
|
(4)
|
5/9/2013
|
|
M
|
|
|
369
|
(4)
|
(4)
|
Common Stock
|
369
|
$0
|
429
|
D
|
|
|
Explanation of Responses:
|
|
(
1)
|
Reflects (1) change in form of ownership of 6,948 shares from indirect through Grantor Retained Annuity Trust formed on 10/04/2010 (2010 GRAT) to direct, following 2010 GRAT annuity payment to the reporting person on 12/04/2012, and (2) excludes 10,526 shares previously owned directly, which were contributed to a Grantor Retained Annuity Trust formed on 12/20/2012 (2012 GRAT).
|
|
(
2)
|
Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest 100% on the date of IDEXX Laboratories, Inc.'s next annual stockholders' meeting, which is currently scheduled to be held on 05/07/2014.
|
|
(
3)
|
Grant of options to buy shares of common stock that vest on the date of IDEXX Laboratories, Inc.'s next annual stockholders' meeting, which is currently scheduled to be held on 05/07/2014.
|
|
(
4)
|
Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest 100% one year from the date of grant (05/09/2013).
|
Reporting Owners
|
|
Reporting Owner Name / Address
|
Relationships
|
|
Director
|
10% Owner
|
Officer
|
Other
|
MURRAY ROBERT J
ONE IDEXX DRIVE
WESTBROOK, ME 04092
|
X
|
|
|
|
Signatures
|
|
Jennifer L. Panciocco, Attorney-in-Fact for Robert J. Murray
|
|
5/10/2013
|
|
**
Signature of Reporting Person
|
Date
|
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
IDEXX Laboratories (NASDAQ:IDXX)
過去 株価チャート
から 7 2024 まで 8 2024
IDEXX Laboratories (NASDAQ:IDXX)
過去 株価チャート
から 8 2023 まで 8 2024
